• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.76% Nasdaq Down0.99%

    Seattle Genetics, Inc. (SGEN)

    -NasdaqGS
    40.38 Down 1.87(4.43%) 2:20PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014
    Total Revenue 77,096   82,157   74,326   75,853  
    Cost of Revenue8,579  8,384  16,581  (383)
    Gross Profit 68,517   73,773   57,745   76,236  
    Operating Expenses
    Research Development85,737  63,395  64,043  58,510  
    Selling General and Administrative30,343  32,121  29,435  25,342  
    Non Recurring -   -  (8,009)8,009  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (47,563) (21,743) (27,724) (15,625)
    Income from Continuing Operations
    Total Other Income/Expenses Net61  53  1,040  59  
    Earnings Before Interest And Taxes(47,502)(21,690)(26,684)(15,566)
    Interest Expense -   -   -   -  
    Income Before Tax(47,502)(21,690)(26,684)(15,566)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(47,502)(21,690)(26,684)(15,566)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (47,502) (21,690) (26,684) (15,566)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (47,502) (21,690) (26,684) (15,566)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.